Joana Vindeirinho, PhD,  —

Joana is a Science Writer at BioNews. She is a cell biologist with a PhD in neurobiology of disease (University of Coimbra, Portugal), focused on the role of the adenosinergic system in the early stages of diabetic retinopathy. She moved from research into high-impact medical editing in 2017, before shifting into a more direct science writing and communication role in 2022.

Articles by Joana Vindeirinho

TeraImmune, NIAID Partnership Extended to Boost Treg Therapies

TeraImmune is extending its collaboration with the National Institute of Allergy and Infectious Diseases (NIAID) to continue developing regulatory T-cell-based therapies for multiple sclerosis (MS) and other autoimmune diseases. The extension will let the company continue optimize the manufacturing process for its lead regulatory T-cell (Treg) product in…

PoNS Device Now Available Online to Patients in US

People with multiple sclerosis (MS) in the U.S. now may order a Portable Neuromodulation Stimulator (PoNS) device online through a new e-commerce site launched by the device’s developer, Helius Medical Technologies. The website, built in partnership with the telehealth company UpScript, marks the first time…

Noninvasive Brain Stimulation Can Ease Some MS Symptoms: Review

Noninvasive brain stimulation (NIBS) may be able to reduce fatigue, spasticity, and pain, and improve quality of life in patients with multiple sclerosis (MS), a new meta-analysis reports. The review assessed several NIBS interventions targeting different brain regions. The results suggest that these techniques can have immediate effects…

Damian Washington video 2 thumbnail